Stay updated on ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page shows a minor site version update: Revision v3.4.2 added and Revision v3.4.1 removed. This change does not affect the study data or history content displayed on the page.
    Difference
    0.1%
    Check dated 2026-02-13T12:55:31.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision history shows the addition of v3.4.1 and the deletion of v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T23:37:55.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The Record History shows a new revision entry (v3.3.4) added and the previous revision (v3.3.3) removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T04:49:02.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 in the page footer; these are administrative history/version updates and do not affect study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-24T14:41:08.000Z thumbnail image
  6. Check
    91 days ago
    Change Detected
    Summary
    New revision entry v3.3.2 added and v3.2.0 removed from the Record History page (NCT05446298). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:15:38.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Removed a site-wide notice about funding and NIH operating status from the page. The core trial history content remains unchanged.
    Difference
    0.7%
    Check dated 2025-11-18T07:23:30.000Z thumbnail image

Stay in the know with updates to ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.